Your browser doesn't support javascript.
loading
P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression.
Coronado, P J; Vidart, J A; Lopez-asenjo, J A; Fasero, M; Furio-bacete, V; Magrina, J; Escudero, M.
Affiliation
  • Coronado PJ; Department of Obstetrics and Gynecology, Hospital Clínico San Carlos, Madrid, Spain. pcoronadom@sego.es
Eur J Obstet Gynecol Reprod Biol ; 98(1): 103-8, 2001 Sep.
Article in En | MEDLINE | ID: mdl-11516808
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Gene Expression / Genes, p53 / Endometrial Neoplasms / Genes, erbB-2 / Neoplasm Recurrence, Local Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2001 Document type: Article Affiliation country: Spain Country of publication: Ireland
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Gene Expression / Genes, p53 / Endometrial Neoplasms / Genes, erbB-2 / Neoplasm Recurrence, Local Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2001 Document type: Article Affiliation country: Spain Country of publication: Ireland